Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

22.26

-0.88 (-3.80%)

At close: Aug 12, 2026, 4:00 PM EDT

22.50

+0.24 (1.08%)

After-hours: Aug 12, 2026, 4:10 PM EDT

Caris Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	989.61	812.03	412.26	306.13	258.49
Revenue Growth	85.37%	96.97%	34.67%	18.43%	-
Cost of Revenue	69.33	272.87	233.48	216.82	178.46
Gross Profit	920.28	539.17	178.78	89.31	80.02
Selling, General & Admin	418.96	392.47	321.99	291.98	294.51
Research & Development	117.14	101.58	113.92	116.88	101.27
Total Operating Expenses	536.1	494.06	435.9	408.86	395.78
Operating Income	153.26	45.11	-257.12	-319.55	-315.76
Interest Income	28.03	16.5	7.12	11.26	0.95
Interest Expense	-46.9	-56.85	-50.03	-31.61	-26.68
Other Non-Operating Income (Expense)	-29.37	-72.85	18.14	-1.51	20.66
Total Non-Operating Income (Expense)	-48.24	-113.2	-24.77	-21.86	-5.07
Pretax Income	105.02	-68.09	-281.89	-341.42	-320.83
Provision for Income Taxes	0.11	-	-	-	-
Net Income	-1.15	-68.09	-281.89	-341.42	-320.83
Net Income Attributable to Preferred Dividends	-	-	96.37	121.11	-
Net Income to Common	-2.29	-68.09	-378.26	-462.53	-320.83
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	282	167	35	35	33
Shares Outstanding (Diluted)	290	167	35	35	33
Shares Change	573.64%	371.04%	1.59%	4.73%	-
EPS (Basic)	0.38	-3.22	-10.66	-13.24	-12.00
EPS (Diluted)	0.36	-3.22	-10.66	-13.24	-12.00
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Free Cash Flow	123.96	66.9	-253.64	-298.42	-327.96
Free Cash Flow Growth	-	-	-	-	-
Free Cash Flow Per Share	0.43	0.40	-7.15	-8.54	-9.83
Gross Margin	92.99%	66.40%	43.37%	29.17%	30.96%
Operating Margin	15.49%	5.56%	-62.37%	-104.38%	-122.16%
Profit Margin	-0.12%	-8.38%	-68.38%	-111.53%	-124.12%
FCF Margin	12.53%	8.24%	-61.52%	-97.48%	-126.88%
EBITDA	174.03	67.73	-208.21	-270.55	-267.5
EBITDA Margin	17.59%	8.34%	-50.50%	-88.38%	-103.49%
EBIT	153.26	45.11	-257.12	-319.55	-315.76
EBIT Margin	15.49%	5.56%	-62.37%	-104.38%	-122.16%
Effective Tax Rate	0.11%	0.00%	0.00%	0.00%	0.00%

SEC Filings: 10-K · 10-Q